CION Ameerpet
Fertility & Hormones · Reviewed by CION Oncologists · NABH Accredited
Endometrial Cancer and Fertility — Can You Keep Your Uterus?
Being told you have a cancer of the womb before you have had children is a particular kind of blow, and the first question is almost always the same one. For a defined group of younger women, the answer is yes — the uterus can be kept, at least for a time. Fertility-sparing treatment is recognised in international guidelines, not a favour or an experiment. It is also not for everyone, it asks a great deal in return, and it carries a higher risk of the cancer returning than surgery does. This page sets out honestly who qualifies, what it involves, and what you would be accepting.
- It is a recognised option — in guidelines, for carefully selected women — not an off-protocol favour
- The criteria are strict — grade 1, confined to the lining, no invasion of the muscle wall
- Hormone treatment replaces surgery — with repeat biopsies every few months as the safety mechanism
- The risk is real and should be stated — recurrence is more likely than after hysterectomy
17+
Cancer Specialists
on Panel
on Panel
35+
Centres
Across India
Across India
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
The Honest Position, Stated First
A page about keeping your uterus should be clear about the trade-off before it describes the option, because a woman making this decision deserves the difficult sentence early rather than buried.
Hysterectomy is the more certain treatment. It removes the cancer and it removes the organ the cancer would return to. Fertility-sparing treatment does neither; it suppresses the tumour and leaves the uterus in place. Recurrence is meaningfully more common after conservative treatment than after surgery.
And alongside that, three things which are equally true:
- For eligible women, the great majority respond. Grade 1 tumours confined to the lining regress on progestin treatment in most women who take it properly, and pregnancies do follow.
- Recurrence is usually detected early, and is usually still treatable. That is what the repeat biopsies are for. A recurrence found on surveillance sampling is generally managed by proceeding to the hysterectomy that was deferred.
- The choice is genuinely yours to make. A woman who understands the trade-off and chooses to accept some additional risk in order to try for a child is making a reasonable decision, not a reckless one. The job of the team is to make sure she understands it — not to make it for her.
What this option is not: a way to avoid surgery in general. It exists for women who want to become pregnant, and it usually comes with an understanding that the uterus will be removed once that is complete. See completing treatment after childbearing.
Did You Know? The reason fertility-sparing treatment is possible at all is a quirk of who gets endometrial cancer young. In younger women, the disease is overwhelmingly driven by prolonged unopposed oestrogen — chronic anovulation, polycystic ovary syndrome, obesity — rather than by the aggressive biology seen in older, non-endometrioid tumours. The result is that early-onset endometrial cancer is very often grade 1, endometrioid, confined to the lining, and richly supplied with hormone receptors. It is a tumour type that responds to being given the progesterone it never had. That is not luck; it is the mechanism of the disease working in the patient’s favour. Sources: ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma; NCCN Clinical Practice Guidelines in Oncology — Uterine Neoplasms; ESHRE guidance on female fertility preservation.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Who Is Eligible — the Criteria in Full
These are not negotiable, and the reason is straightforward: the safety of the whole approach rests on being certain the tumour is confined to the lining. Every criterion below is there to establish that.
| Requirement | Why it is there |
|---|---|
| Grade 1 endometrioid carcinoma | Higher grades and non-endometrioid types behave more aggressively and are far less likely to respond to hormone treatment. This is the single firmest criterion. See endometrial cancer grades. |
| No invasion of the muscle wall | Assessed on MRI. Invasion means the tumour has left the compartment that hormone treatment can reliably reach, and raises the risk of spread to lymph nodes. |
| No evidence of disease outside the uterus | Imaging must show no involvement of the ovaries, nodes or anywhere beyond. Conservative treatment does nothing for disease that has already travelled. |
| Pathology confirmed by expert review | The distinction between atypical hyperplasia, grade 1 carcinoma and grade 2 carcinoma decides the whole plan and is a difficult call. It should be reviewed, not accepted from a single report. |
| A current wish to conceive | The option exists to preserve fertility and carries risk in exchange. It is not offered simply to avoid an operation. |
| Willingness to attend surveillance | Repeat biopsies every few months are the mechanism that makes this safe. A woman who cannot commit to them is not a candidate, and saying so is not a judgement about her. |
| No contraindication to progestin treatment | A history of blood clots, certain liver conditions and some other factors make high-dose progestin unsafe, and would need weighing individually. |
If you are in this situation, raise it before you consent to surgery. Once the uterus has been removed the conversation is over, and it is a conversation that is much easier to have too early than too late. If a hysterectomy has been recommended and nobody has asked whether you want children, that is a reasonable thing to raise yourself.
Young, Newly Diagnosed, and Nobody Has Mentioned This?
It is worth one appointment to find out whether you are eligible — before surgery is scheduled rather than after.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
This Conversation Is Much Easier Before Surgery Than After
If you want children and have been told you need a hysterectomy, ask whether fertility-sparing treatment applies to you.
What actually happens
The Pathway, Step by Step
From the first conversation to a completed family, this is a route measured in years rather than months. Knowing the shape of it in advance makes the waiting easier.
Establishing eligibility properly
Before anything is started, the diagnosis is confirmed and the tumour is characterised. That means expert review of the pathology slides, because the distinction between atypical hyperplasia, grade 1 and grade 2 carcinoma decides everything that follows; MRI of the pelvis to look for any invasion into the muscle wall; and hysteroscopy in many cases, so the cavity is seen directly and sampled under vision rather than blind. Molecular testing, including mismatch repair status, is also done — both because it informs the outlook and because a deficient result may signal Lynch syndrome, which changes the whole conversation about future risk.
Starting treatment
The treatment is a progestin at high dose, delivered either by a hormone-releasing intrauterine device placed directly in the cavity, or orally, or sometimes both together. The device has the advantage of putting a very high concentration exactly where it is needed with much less reaching the rest of the body, and of not depending on remembering tablets. Irregular bleeding in the first months is expected and is not a sign of failure. Alongside this, the underlying cause matters: where obesity or anovulation drove the tumour, addressing them improves the odds of the treatment working and of a subsequent pregnancy. See fertility-sparing progestin therapy.
Surveillance sampling — the part that makes it safe
Repeat endometrial sampling at intervals of a few months, usually with hysteroscopy so the cavity is seen as well as sampled. This is not a formality and it is not optional; it is the entire mechanism by which conservative management is made defensible. Most women who respond do so within the first six to nine months. A tumour that has not regressed within the agreed window is a signal to proceed to surgery, and that endpoint should be agreed at the very start rather than negotiated later when it is emotionally much harder.
Trying to conceive — and why the referral comes early
Regression is not the goal in itself; a baby is. Once the lining has cleared, the window before the tumour can return is finite, so referral to reproductive medicine is made early rather than after a long wait. Assisted reproduction is frequently involved, for two reasons: it shortens the time to conception, and many women in this situation have exactly the anovulatory background that caused the cancer and would struggle to conceive naturally. Reproductive medicine is a coordinated referral rather than something delivered in-house, and arranging it is part of the plan. See IVF after endometrial cancer.
Pregnancy itself
Pregnancy after fertility-sparing treatment is generally managed as higher risk, with obstetric input, but many women go on to have healthy babies. There is also an argument that pregnancy itself is protective, since it floods the endometrium with progesterone for months. What does need planning is what happens between pregnancies if more than one child is wanted, because surveillance has to continue in the intervals. See pregnancy after treatment.
Completing treatment
Once childbearing is finished, hysterectomy is generally recommended. This is the part that is easiest to defer indefinitely and hardest to face, because by then the woman feels well and the cancer feels like history. But the uterus that developed one cancer, in a hormonal environment that has often not changed, remains at risk — and recurrences have been reported years later. Agreeing the principle at the outset, when the whole plan is being set up, makes this conversation much easier when it arrives. See completing treatment with hysterectomy.
Want to Know Whether You Are Eligible?
It takes a pathology review and an MRI to answer properly. Worth doing before any surgery is scheduled. The opinion is free.
The Other Half of This Cluster: Menopause After Surgery
Fertility is one of the two hormone questions this diagnosis raises, and the second affects far more women. If your ovaries are removed as part of the operation and you had not yet reached the menopause, you will go into it within days.
This is not a footnote to cancer treatment. Surgical menopause before the natural age is more abrupt than a natural transition and carries long-term consequences for bone density and cardiovascular health that need active management rather than endurance.
- The symptoms start quickly and are often severe. Hot flushes, sleep disruption, mood change, vaginal dryness. Being told this is “expected” is not the same as being helped with it. See surgical menopause.
- Hormone replacement after endometrial cancer is a real question with a real answer. It is not automatically forbidden, and blanket refusals are common and often wrong. It depends on stage, grade and histology, and deserves a proper discussion. See HRT after endometrial cancer.
- Bone health needs attention from the start. Early oestrogen loss accelerates bone loss for decades, and the interventions are most effective early. See bone health after early menopause.
- Sexual health is a clinical topic. Dryness, discomfort and loss of desire after surgical menopause are treatable, and raising them is not a trivial use of an appointment. See intimacy after treatment.
Fertility and Hormones — Every Guide
Two audiences, one cluster: women hoping to conceive, and women managing menopause after surgery.
- Fertility-sparing progestin therapy explained
- The hormone IUD for fertility-sparing treatment
- Pregnancy after fertility-sparing treatment
- IVF & assisted reproduction after endometrial cancer
- Who is eligible for fertility-sparing treatment?
- Surgical menopause after ovary removal
- Can you take HRT after endometrial cancer?
- Managing early menopause after treatment
- Recurrence risk with fertility-sparing treatment
- Completing treatment with hysterectomy after childbearing
Why This Decision Needs a Team That Will Take It Seriously
The commonest failure here is not a bad outcome. It is nobody asking the question before the operation.
Fertility taken seriously
Slides reviewed, not just the summary line
Tumour board for every diagnosis
MMR / MSI testing as standard
Lynch counselling built in
45-minute consultations
Take The Next Step
Ask the Question Before the Operation Is Booked
If you want children, that belongs in the first conversation about your treatment — not the last.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Endometrial Cancer & Fertility — Frequently Asked Questions
Can I have children after endometrial cancer?
It depends entirely on whether you are eligible for fertility-sparing treatment, and that has to be established before any surgery. If a hysterectomy has already been performed, pregnancy is not possible, though surrogacy remains an option if the ovaries were preserved and eggs can be retrieved. For a defined group of younger women — grade 1 endometrioid tumours confined to the lining with no invasion of the muscle wall, and no disease outside the uterus — hysterectomy can be deferred and high-dose progestin treatment used instead, with repeat biopsies every few months. Most eligible women who take the treatment properly do see the tumour regress, and pregnancies do follow, frequently with the help of assisted reproduction.
Is fertility-sparing treatment safe?
It is recognised in international guidelines for carefully selected women, which means it is an accepted option rather than an experiment — but it is less certain than surgery and it is honest to say so. Hysterectomy removes the cancer and removes the organ it would return to; progestin treatment suppresses the tumour and leaves the uterus in place, so recurrence is meaningfully more common. What makes the approach defensible is the surveillance: repeat endometrial sampling every few months means that if the tumour returns or fails to regress, it is usually detected early and managed by proceeding to the hysterectomy that was deferred. A woman who cannot commit to that sampling is not a suitable candidate.
Who qualifies for fertility-sparing treatment?
The criteria are strict, and each one exists to establish that the tumour is genuinely confined to the lining. You need a grade 1 endometrioid carcinoma; no invasion into the muscle wall of the uterus on MRI; no evidence of disease outside the uterus; pathology confirmed by expert review rather than accepted from a single report; a current wish to become pregnant; willingness to attend repeat biopsies every few months; and no medical reason that high-dose progestin would be unsafe, such as a history of blood clots. Higher-grade tumours and non-endometrioid types are excluded because they behave more aggressively and respond poorly to hormone treatment.
Will I have to have a hysterectomy eventually?
It is generally recommended once childbearing is complete, and that expectation should be set out at the very beginning rather than raised years later. The reasoning is that the uterus which developed one cancer remains at risk, particularly if the hormonal conditions that caused it — anovulation, excess weight, unopposed oestrogen — have not changed, and recurrences have been reported well after apparently successful treatment. Some women defer it and continue with surveillance instead, which is a decision to be made with a specialist and with a clear understanding of what is being accepted. What is not reasonable is simply drifting away from follow-up once a baby has arrived.
What if my ovaries are removed — is there anything that helps?
Yes, and this matters for far more women than fertility-sparing treatment does. If your ovaries are removed before you have reached the natural menopause, symptoms begin within days and are usually more abrupt than a natural transition, with longer-term consequences for bone density and cardiovascular health. These are treatable rather than things to endure. Non-hormonal options exist for hot flushes and sleep, local treatment helps vaginal dryness considerably, and bone health should be addressed early because that is when intervention works best. Hormone replacement after endometrial cancer is not automatically forbidden — it depends on stage, grade and histology, and blanket refusals are common and often wrong. Ask for the question to be considered properly.
Medical disclaimer: This page describes fertility-sparing treatment for endometrial cancer in general terms and is reviewed by a CION oncologist, following current NCCN and ESGO–ESTRO–ESP guidance. It describes treatment by hormone class rather than naming individual medicines. Eligibility depends on pathology and imaging specific to you and can only be established by a specialist team. Assisted reproduction is arranged through reproductive medicine services rather than provided in-house. This is not advice about your own case, and decisions should be made before any surgery is scheduled.